LEXX | Lexaria Bioscience Corp. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)

*Sign In to persist settings

Financial Year End	2024-08-31	2023-08-31	2022-08-31	2021-08-31	2020-08-31	2019-08-31	2018-08-31	2017-08-31	2016-08-31	2015-08-31	2014-08-31	2012-10-31	2011-10-31	2010-10-31	2009-10-31	2008-10-31	2007-10-31	2006-10-31	2005-10-31
Revenue	464.28K	226.21K	255.40K	722.74K	384.54K	222.61K	433.29K	63.64K	40.72K	14.70K	1.10M	1.36M	1.13M	362.47K	421.95K	900.79K	253.15K	20.31K	20.31K
Cost of Revenue	4.82K	31.50K	71.84K	175.35K	99.38K	22.89K	25.18K	29.75K	45.62K	29.88K	795.20K	783.27K	667.86K	273.62K	548.32K	912.75K	124.91K	93.32K	93.32K
Gross Profit	459.46K	194.71K	183.56K	547.39K	285.17K	199.72K	408.10K	33.89K	-4.90K	-15.18K	302.25K	574.49K	465.91K	88.86K	-126.37K	-11.96K	128.24K	-73.01K	-73.01K
Operating Expenses	6.21M	6.73M	7.57M	6.23M	4.27M	4.26M	7.01M	1.90M	1.21M	1.91M	8.19K	579.40K	725.41K	474.00K	467.18K	480.72K	1.18M	138.53K	35.14K
Selling, General & Admin	3.85M	3.06M	5.72M	4.97M	3.77M	3.64M	6.51M	1.84M	1.20M	1.76M	8.19K	565.35K	719.01K	467.23K	458.97K	479.45K	1.03M	141.51K	35.14K
Research & Development	2.36M	3.67M	1.84M	1.26M	387.07K	555.73K	492.86K	54.19K	9.02K	146.47K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Other Operating Expenses	N/A	N/A	N/A	N/A	112.75K	60.55K	2.31K	-886.00	4.60K	-22.66K	N/A	14.04K	6.40K	N/A	8.21K	1.27K	148.38K	-2.99K	N/A
Operating Income	-5.75M	-6.53M	-7.38M	-5.69M	-3.89M	-3.96M	-6.60M	-1.86M	-1.22M	-1.93M	294.06K	-4.90K	-259.50K	-552.46K	-753.67K	-898.09K	-1.05M	-489.66K	-35.14K
Other Expenses / Income	-42.22K	-178.50K	-764.61K	1.52M	N/A	-228.06K	-8.97K	-6.01K	-34.70K	-55.06K	-355.23K	-246.61K	-276.22K	-278.73K	N/A	7.05K	-73.27K	-565.19K	-473.12K
Before Tax Income	-5.80M	-6.71M	-7.38M	-4.16M	-4.08M	-4.16M	-6.61M	-1.93M	-1.28M	-1.98M	-1.87M	-251.51K	-538.23K	-552.46K	-753.67K	-971.35K	-1.05M	-211.54K	-75.58K
Income Tax Expenses	N/A	N/A	-114.33K	-1.66M	-54.29K	39.62K	-8.97K	-54.17K	-60.23K	-181.23K	294.06K	246.61K	278.73K	167.32K	-94.00	7.14K	1.04K	574.84K	40.59K
Net Income	-5.80M	-6.66M	-7.27M	-2.50M	-4.03M	-4.20M	-6.60M	-1.87M	-1.21M	-1.77M	-1.87M	-251.51K	-538.23K	-552.46K	-753.57K	-978.49K	-1.06M	-508.26K	-75.72K
Interest Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	6.01K	2.25K	31.54K	267.36K	246.61K	278.73K	167.32K	160.12K	857.58K	4.71K	21.91K	21.91K
Basic Shares Outstanding	12.38M	6.61M	5.89M	4.39M	2.77M	2.59M	2.37M	1.96M	1.46M	1.32M	25.71M	602.48K	493.23K	451.94K	268.67K	219.28K	202.59K	160.87K	55.15K
Diluted Shares Outstanding	12.38M	6.61M	5.89M	4.39M	2.77M	2.59M	2.37M	1.96M	1.46M	1.32M	25.71M	602.48K	493.23K	451.94K	268.67K	219.28K	202.59K	160.87K	55.15K
EBITDA	-5.75M	-6.39M	-6.52M	-5.58M	-4.00M	-4.10M	-6.61M	-1.92M	-1.26M	-1.95M	294.06K	-35.30K	442.73K	111.12K	-236.15K	-244.37K	-414.37K	-891.03K	-129.78K
EBITDA Margin	-1,239.16%	-2,824.23%	-2,551.45%	-771.39%	-1,040.90%	-1,840.83%	-1,524.83%	-3,020.10%	-3,091.99%	-13,269.46%	26.79%	-2.60%	39.05%	30.66%	-55.97%	-27.13%	-163.69%	-4,387.80%	-639.09%
EBIT	-5.80M	-6.66M	-7.38M	-4.16M	-4.08M	-4.16M	-6.61M	-1.92M	-1.27M	-1.92M	-1.31M	241.70K	19.22K	-217.82K	-593.55K	-113.77K	-1.05M	88.49K	-13.23K
EBIT Margin	-1,248.25%	-2,946.36%	-2,891.05%	-576.16%	-1,062.20%	-1,868.03%	-1,525.04%	-3,012.99%	-3,125.77%	-13,060.69%	-119.35%	17.80%	1.70%	-60.09%	-140.67%	-12.63%	-414.83%	435.76%	-65.14%
Financial Year End	2024-08-31	2023-08-31	2022-08-31	2021-08-31	2020-08-31	2019-08-31	2018-08-31	2017-08-31	2016-08-31	2015-08-31	2014-08-31	2012-10-31	2011-10-31	2010-10-31	2009-10-31	2008-10-31	2007-10-31	2006-10-31	2005-10-31